lily glp 1 Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials Administration Anounces Landmark GLP-1 Pricing
Description
Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C
Let me give you specific numbers, because vague advice like eat more protein doesnt help when you can barely stomach a full meal
Dysesthesia, an abnormal sensation often described as tingling, burning, or numbness in the skin, appeared in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose, compared to just 0.7% on placebo
The proposed mechanism centers on the gut microbiome's role in metabolic regulation
